Complicated and deep bacterial skin and soft tissue infections

被引:0
|
作者
Prodinger, Christine [1 ]
Lechner, Arno [2 ]
Hintersteininger, Arno [1 ]
Kern, Jan Marco [2 ]
Meissnitzer, Matthias [3 ]
Meyersburg, Damian [1 ]
Bauer, Johann W. [1 ]
Laimer, Martin [1 ]
机构
[1] Paracelsus Med Privatuniv Salzburg, Univ Klin Dermatol & Allergol, Univ Klinikum, Salzburg, Austria
[2] Paracelsus Med Privatuniv Salzburg, Univ Klin Klin Mikrobiol & Hyg, Univ Klinikum, Salzburg, Austria
[3] Paracelsus Med Privatuniv Salzburg, Univ Inst Radiol, Univ Klinikum, Salzburg, Austria
关键词
Antibiotic Therapy; Bacterial Skin and Soft Tissue Infections; Erysipelas; Microbiological Diagnostics; Necrotizing Fasciitis; NECROTIZING FASCIITIS; CELLULITIS; DIAGNOSIS; THERAPY; IMMUNOGLOBULIN; COMBINATION; MANAGEMENT; EFFICACY; SCORE; RISK;
D O I
10.1111/ddg.15493_g
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Complicated erysipelas, cellulitis, and necrotizing soft tissue infections belongto the spectrum of bacterial infections affecting the skin and underlying softtissues. Their frequency as well as risk of recurrence and complicated diseasecourse pose a significant health burden. The latter is further impacted by global travel activity, associated variations in the prevalence of microbes, the emer-gence of multi-resistant bacteria, demographically driven aging with increaseof critical comorbidities, immunosuppressive therapies as well as excessive (alsonon-medical) use of antibiotics.Against this background, early and accurate diagnosis and immediately promptedtherapeutic measures are major determinants of prognosis and clinical outcome.Diagnostic evaluation involves clinical, laboratory, microbiological and radiogra-phic findings which are assessed in the context of patient-specific risk factorsand comorbidities. First and foremost, given the indication, exploratory incisionsof lesional tissue should be obtained which allow to instantaneously assess theextent of tissue necrosis and provide guidance on the scope and extent of further(surgical and non-surgical) treatment modalities. Thereby, delayed or inadequateinterventions are avoided which reduces duration of treatment, health expenses,the risk of recurrent hospitalizations, as well as mortality rates.
引用
收藏
页码:357 / 376
页数:20
相关论文
共 50 条
  • [1] Complicated skin and soft tissue infections
    Kujath, P.
    Eckmann, C.
    Bouchard, R.
    Esnaashari, H.
    ZENTRALBLATT FUR CHIRURGIE, 2007, 132 (05): : 411 - 418
  • [2] Treatment of Complicated Skin and Soft Tissue Infections
    May, Addison K.
    Stafford, Renae E.
    Bulger, Eileen M.
    Heffernan, Daithi
    Guillamondegui, Oscar
    Bochicchio, Grant
    Eachempati, Soumitra R.
    SURGICAL INFECTIONS, 2009, 10 (05) : 467 - 499
  • [3] Bacterial skin and soft tissue infections
    Hanses, Frank
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2017, 76 (09): : 745 - 751
  • [4] Bacterial skin and soft tissue infections
    Sukumaran, Vichitra
    Senanayake, Sanjaya
    AUSTRALIAN PRESCRIBER, 2016, 39 (05) : 159 - 163
  • [5] Clinical metagenomics for complicated skin and soft tissue infections
    Yang, Wan-Ting
    Lai, Chih-Sheng
    Lai, Kuo-Lung
    Mao, Yan-Chiao
    Liu, Po-Yu
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2021, 58 : 34 - 35
  • [6] Bacterial infections of the skin and soft tissue in the neonate
    Sarlangue, J
    Boralevi, F
    Barba, G
    Leauté-Labrèze, C
    ARCHIVES DE PEDIATRIE, 2001, 8 : 462S - 464S
  • [7] BACTERIAL SKIN AND SOFT-TISSUE INFECTIONS
    JOHNSON, RA
    CURRENT OPINION IN INFECTIOUS DISEASES, 1992, 5 (05) : 695 - 702
  • [8] Complicated skin and soft tissue infections in remote indigenous communities
    Thomas, Lauren
    Bowen, Asha C.
    Tong, Steven Y. C.
    INTERNAL MEDICINE JOURNAL, 2020, 50 (06) : 752 - 754
  • [9] Effectiveness of Ceftarolin in complicated Skin- and Soft Tissue Infections
    Eckmann, C.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2014, 139 : S87 - S88
  • [10] A practical guide to the treatment of complicated skin and soft tissue infections
    Fung, HB
    Chang, JY
    Kuczynski, S
    DRUGS, 2003, 63 (14) : 1459 - 1480